Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/09/2005US6926899 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926897 comprising a fusion protein from at least one L1 protein of papillomaviruses and at least one E protein papillomaviruses, the fusion protein containing no papillomavirus-unspecfic epitopes
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005US6926408 Continuous two-dimensional corneal topography target
08/09/2005CA2362431C Methods of using viral replicase
08/09/2005CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
08/09/2005CA2145400C Biotechnological method of producing biotin
08/09/2005CA2135278C Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
08/09/2005CA2109098C Activity-dependent neurotrophic factor
08/09/2005CA2012778C Disease-resistant transgenic plants
08/06/2005CA2464205A1 Use of ricin oil as anti-inflammatory agent
08/04/2005WO2005071387A1 Methods for diagnosis and pronosis of cancers of epithelial origin
08/04/2005WO2005071093A2 Chimpanzee adenovirus vaccine carriers
08/04/2005WO2005071083A1 An arabidopis thaliana transcription factoras well as the encoding gene and the use thereof
08/04/2005WO2005071081A1 Eosinophil-deficient transgenic animals
08/04/2005WO2005071076A1 Gene markers linked to fusarium head blight-resistance factor and utilization thereof
08/04/2005WO2005071075A1 Peptide originating in epidermal growth factor receptor (egfr)
08/04/2005WO2005071074A1 Transformed saccharomyces cerevisiae and method for mass-production of lk8 protein using the same
08/04/2005WO2005071073A1 Fap compositions and the use thereof for immunomodulation
08/04/2005WO2005071069A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005WO2005071068A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS
08/04/2005WO2005071062A1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
08/04/2005WO2005070966A2 Fusion polypeptides capable of activating receptors
08/04/2005WO2005070965A2 Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases
08/04/2005WO2005070961A1 Human organic solute transporters
08/04/2005WO2005070960A1 Site-specific coupling of polypeptides
08/04/2005WO2005070958A2 Lawsonia intracellularis subunit vaccines
08/04/2005WO2005070957A1 Hcv rna-dependent rna polymerase
08/04/2005WO2005070956A1 Analogues of antimicrobial peptide synthesized and produced from gaegurin 5
08/04/2005WO2005070953A1 Purification of high-molecular compounds by means of affinity membrane chromatography
08/04/2005WO2005070827A2 Fullerene based amino acids
08/04/2005WO2005070468A2 Transglutaminase mediated conjugation of peptides
08/04/2005WO2005070454A2 A novel process of hepatitis a vaccine preparation
08/04/2005WO2005070451A1 Pharmaceutical composition comprising non-glycosylated erythropoietin
08/04/2005WO2005070448A2 Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
08/04/2005WO2005070214A2 Peptides for inhibiting insects
08/04/2005WO2005070199A1 Mouse model for psoriasis and psoriatic arthritis
08/04/2005WO2005070195A1 Transgenic plant having increased seed weight and utilization thereof
08/04/2005WO2005070180A2 Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
08/04/2005WO2005070148A2 Methods of using high affinity atiii variants
08/04/2005WO2005070138A2 O-linked glycosylation of peptides
08/04/2005WO2005070136A2 Up-regulation of bone morphogenetic protein (bmp) gene expression in bone cells by electromagnetic signals
08/04/2005WO2005070041A2 Modulating vaccine against hiv nef protein-induced lymphocyte depletion
08/04/2005WO2005070023A2 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
08/04/2005WO2005069994A2 Folate conjugates and complexes
08/04/2005WO2005069969A2 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005WO2005069913A2 Expression of mammalian proteins in pseudomonas fluorescens
08/04/2005WO2005069900A2 Npc1l1 (npc3) and methods of identifying ligands thereof
08/04/2005WO2005069859A2 Compositions and methods for modulating dhr96
08/04/2005WO2005069854A2 Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides
08/04/2005WO2005069852A2 Primary central nervous system tumor specific behab isoforms
08/04/2005WO2005069845A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005WO2005069762A2 Bacillus licheniformis chromosome
08/04/2005WO2005069726A2 Hybrid and chimeric polypeptides that regulate activation of complement
08/04/2005WO2005061532A8 Pathogenic infection detection compositions and methods
08/04/2005WO2005059131A3 Protein binding miniature proteins and uses thereof
08/04/2005WO2005058865A3 Assay for entactogens
08/04/2005WO2005054426A3 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
08/04/2005WO2005054281A3 Protein nmb1125 and use thereof in pharmaceutical formulations
08/04/2005WO2005052586A3 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
08/04/2005WO2005052001A3 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
08/04/2005WO2005051990A3 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer
08/04/2005WO2005049793A3 Methods and compositions for combinatorial approaches to cancer gene therapy
08/04/2005WO2005047319A3 Dna sequence and expressed recombinant glycoproteins related to feline thyrotropin
08/04/2005WO2005037865A3 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR
08/04/2005WO2005037863A3 Alternative splicing factors polynucleotides, polypeptides and uses thereof
08/04/2005WO2005027827A3 Host defense factor x (hdfx)
08/04/2005WO2005027821A3 Large scale preparation of alpha-1 proteinase inhibitor and use thereof
08/04/2005WO2005026342A9 Methods of modulating bone growth, bone remodeling and adiposity
08/04/2005WO2005024041A3 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
08/04/2005WO2005019471A3 Periostin-like factor: compositions and methods for making and using the same
08/04/2005WO2005002516A3 Leukocyte internalized peptide-drug conjugates
08/04/2005WO2004093807A3 Somatostatin vectors
08/04/2005WO2004092360A3 The severe acute respiratory syndrome coronavirus
08/04/2005WO2004089295A3 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
08/04/2005WO2004083234A3 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
08/04/2005WO2004072240A3 Antiplasmin cleaving enzyme
08/04/2005WO2004066966A3 Peptide yy analogs
08/04/2005WO2004060275A3 Wound care compositions
08/04/2005WO2004055158A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005WO2004048408A8 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells
08/04/2005WO2004043238A3 Biomarkers for intra-amniotic inflammation
08/04/2005WO2004020608A3 Modulators of tnf-alpha and il-1 cell surface receptor activity
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2004005316A3 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
08/04/2005WO2004003158A3 Methods and compositions for modulating and detecting wisp activity
08/04/2005WO2003095610A3 Directed evolution method of generating enhanced folding polypeptide variants
08/04/2005WO2003064589A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/04/2005US20050172364 Genes for modifying plant traits XI
08/04/2005US20050172359 Using expression vector comprising phaseolin promoter to transfer and express plasma lipoprotein in seeds
08/04/2005US20050172357 Insect viruses and their uses in protecting plants
08/04/2005US20050172355 Polynucleotide encoding polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects
08/04/2005US20050172351 Animal model for identifying agents that inhibit or enhance CTLA4 signaling
08/04/2005US20050172346 Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3
08/04/2005US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders
08/04/2005US20050172343 Astrocyte modulated genes and uses thereof
08/04/2005US20050172342 Production of collagen in the milk of transgenic mammals
08/04/2005US20050171343 Expression of lipoproteins
08/04/2005US20050171341 Methods for stabilizing proteins
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 2916